June 29, 2015 | As Mylan nears its takeover of Perrigo, Israeli investment institution were ensured by the company that it would maintain Perrigo’s research and development activity in Israel. Perrigo employs some 1,000 Israelis, and not just in its R&D center. In addition, Mylan’s CFO John Sheehan ensured Tel Aviv Stock Exchange CEO Yossi Beinart that Mylan would remain committed to being listed on the TASE following the acquisition. Mylan is expected to acquire Perrigo at a $32.9 billion value, according to estimates.
Subscribe to NoCamels weekly newsletter and get our top stories
Related posts

Israeli Pineapple-Based Burn Therapy Treating Injured US Troops
October 02, 2023

AI Can Predict Future Heart Attacks By Analyzing CT Scans
October 01, 2023

Israeli Startups Create Powerful Drone-Detecting Software
September 28, 2023

Model Sees Daylight As Boost For Hospitalized Patients’ Health
September 28, 2023
Facebook comments